Repros Therapeutics (RPRX) Announces Quarterly Results
Repros Therapeutics (NASDAQ:RPRX) released its earnings data on Tuesday. The company reported ($0.38) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.37) by $0.01, AnalystRatingsNetwork reports.
Repros Therapeutics (NASDAQ:RPRX) opened at 13.96 on Tuesday. Repros Therapeutics has a 52-week low of $12.61 and a 52-week high of $29.79. The stock has a 50-day moving average of $15.43 and a 200-day moving average of $16.9. The company’s market cap is $322.4 million.
Repros Therapeutics, Inc is a United States-based company that develops products and services for the management of reproductive health.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.